ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,833,506 | -24.0% | 422,281 | 0.0% | 0.11% | -21.8% |
| Q1 2023 | $3,728,741 | +15.6% | 422,281 | 0.0% | 0.14% | +16.4% |
| Q4 2022 | $3,226,227 | +7.3% | 422,281 | 0.0% | 0.12% | -0.8% |
| Q3 2022 | $3,007,000 | +10.1% | 422,281 | +25.0% | 0.12% | +15.0% |
| Q2 2022 | $2,732,000 | -41.7% | 337,722 | 0.0% | 0.11% | -35.2% |
| Q1 2022 | $4,688,000 | -50.5% | 337,722 | 0.0% | 0.16% | -45.9% |
| Q4 2021 | $9,476,000 | -17.4% | 337,722 | 0.0% | 0.30% | -17.6% |
| Q3 2021 | $11,479,000 | -16.8% | 337,722 | 0.0% | 0.37% | -17.4% |
| Q2 2021 | $13,799,000 | +1.5% | 337,722 | 0.0% | 0.45% | -4.3% |
| Q1 2021 | $13,597,000 | -19.6% | 337,722 | +18.1% | 0.47% | -21.2% |
| Q4 2020 | $16,912,000 | +1307.0% | 286,013 | +1057.2% | 0.59% | +1220.0% |
| Q3 2020 | $1,202,000 | – | 24,715 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |